Second Malignancies after Treatment for Hodgkin's Disease

References

• van Leeuwen F. E., Swerdlow A. J., Valagussa P., Tucker M. A. Second cancer after treatment of Hodgkin's disease. Hodgkin's Disease, P. M. Mauch, J. O. Armitage, V. Diehi, R. T. Hoppe, L. M. Weiss. Lippincott Williams & Wilkins, Philadelphia 1999; 607–632
   Google Scholar
• Juhasz L. Cancer Incidence in the County Szabolcs-Szatmar-Bereg, Hungary 1990–91. Cancer Series No 14, Nyiregyhaza 1993
   Google Scholar
• Munker R., Hiller E., Melnyk A., Gutjahr P. Second malignancies: clinical relevance and basic research (review). Int. J. Oncol. 1996; 9: 763–776
   PubMed Web of Science ®Google Scholar
• Wolden S. L., Lamborn K. R., Cleary S. F., Tate D. J., Donaldson S. S. Second cancers following pediatric Hodgkin's disease. J. Clin. Oncol. 1998; 16(2)536–544
   PubMed Web of Science ®Google Scholar
• Henry-Aimar M., Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin. Oncol. 1990; 17: 758–768
   PubMed Web of Science ®Google Scholar
• Brierley J. D., Rathmell A. J., Gospodarowicz M. K., et al. Late effects of treatment for early-stage Hodgkin's disease. Br. J. Cancer 1998; 77: 1300–1310
   PubMed Web of Science ®Google Scholar
• Rodriguez M. A., Fuller L. M., Zimmerman S. O., et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann. Oncol. 1993; 4: 125–131
   PubMed Web of Science ®Google Scholar
• Abrahamsen J. F., Andersen A., Hannisdal E., et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment. Follow-up time, and age. J. Clin. Oncol. 1993; 11: 255–261
   PubMed Web of Science ®Google Scholar
• Tura S., Fiacchini M., Zinzani P. L., Brusamolino E., Gobbi P. G. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J. Clin. Oncol. 1993; 11: 925–930
   PubMed Web of Science ®Google Scholar
• Armitage J. O. Long-term toxicity of the treatment of Hodgkin's disease. Ann. Oncol. 1998; 9: S133-S136
   PubMedGoogle Scholar
• Hess C. F., Kortmann R. D., Schmidberger H., Bamberg M. How relevant is secondary leukaemia for initial treatment selection in Hodgkin's disease?. Eur. J. Cancer 1994; 10: 1441–1447
   Web of Science ®Google Scholar
• Hoppe R. T. Long-term complications of treatment for Hodgkin's disease. Trends Onco-Hematol. 1996; 4(3)46–48
   Google Scholar
• Boffetta P., Kaldor J. M. Secondary malignancies following cancer chemotherapy. Acta Oncol. 1994; 33(6)591–598
   PubMed Web of Science ®Google Scholar
• Mauch P. M., Chalice L. A., Marcus K. C., et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87(9)3625–3632
   PubMed Web of Science ®Google Scholar
• Henry-Amar M., Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin. Oncol. 1990; 17(6)758–768
   PubMed Web of Science ®Google Scholar
• Boivin J. F., Hutchison G. B., Zauber A. G., et al. Incidence of second cancer in patients treated for Hodgkin's disease. J. Nat. Cancer Inst. 1995; 87(10)732–734
   PubMed Web of Science ®Google Scholar
• Swerdlow A. J., Barber J. A., Horwich A., Cunningham D., Milan S., Omar R. Z. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br. J. Cancer 1997; 75: 116–123
   PubMed Web of Science ®Google Scholar
• Salloum E., Doria R., Schubert W., et al. second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J. Clin. Oncol. 1996; 9: 2435–2443
   Google Scholar
• Epstein R., Hanham I., Dale R. Radiotherapy-induced second cancers: we doing enough to protect young patients?. Eur. J. Cancer 1997; 4: 526–530
   Web of Science ®Google Scholar
• Sears J. D., Greven K. M., Ferree C. R., D'Agostino R. B. Definitive irradiation in the treatment of Hodgkin's disease. Cancer 1997; 79: 145–151
   PubMed Web of Science ®Google Scholar
• Wolf J., Schellong G., Diehl V. Breast cancer following treatment of Hodgkin's disease—more reasons for less radiotherapy?. Eur. J. Oncol. 1997; 33(14)2293–2294
   Google Scholar
• Aisenberg A. C., Finkelstein D. M., Doppke K. P., Koerner F. C., Boivin J. F., Willett C. G. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997; 79: 1203–1210
   PubMed Web of Science ®Google Scholar
• van Leeuwen F. E., Klokman W. J., Hagenbeek A., et al. second cancer risk following Hodgkin's disease: a 20-year follow-up study. J. Clin. Oncol. 1994; 12(2)312–325
   PubMed Web of Science ®Google Scholar
• Ill O. B., Hudson M. M., Greenwald C., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J. Clin. Oncol. 1995; 3: 603–609
   Google Scholar
• Bhatia S., Robinson L. L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 1996; 334(12)745–750
   PubMed Web of Science ®Google Scholar
• Sankila R., Garwicz S., Olsen J. H., et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five nordic countries. J. Clin. Oncol. 1996; 14(5)1442–1446
   PubMed Web of Science ®Google Scholar
• Zatonski W., Smans M., Tyczynski J., Boyle P. Atlas of cancer mortality in Central Europe. ARC Scientific Publications, Lyon 1996; 134: 30–31
   Google Scholar